glucuronic acid has been researched along with Cardiovascular Stroke in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 20 (68.97) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paul, A; Prakash, S; Shum-Tim, D | 1 |
| Cha, MJ; Hwang, KC; Kim, JK; Kim, YH; Lee, J; Lee, KY; Lee, SK; Lim, KS | 1 |
| Deng, B; Ding, X; Ge, J; Jia, J; Lu, S; Qian, J; Shen, L; Shen, Y; Wu, Y | 1 |
| Brudno, Y; Duffy, GP; Hastings, CL; Lewin, SA; Mooney, DJ; O'Brien, FJ; Roche, ET; Shvartsman, D; Vasilyev, NV; Walsh, CJ | 1 |
| Alsberg, E; Donahue, JK; Laurita, KR; Mesubi, OO; Panda, NC; Penn, MS; Rosenbaum, DS; Zuckerman, ST | 1 |
| Al-Shoukr, F; Azzouna, RB; Bouchemal, N; Chaubet, F; Chauvierre, C; Guludec, DL; Letourneur, D; Louedec, L; Maire, M; Picton, L; Potier, G; Rolland, L; Rouzet, F; Saboural, P | 1 |
| Bea, F; Frey, N; Leor, J; Linke, A; Müller-Ehmsen, J; Rosenberg, M; Schoors, D; Süselbeck, T; Tuvia, S; Vermeersch, P | 1 |
| Agathopoulos, S; Barka, E; Blankesteijn, WM; Daskalopoulos, EP; Kolettis, TM; Kontonika, M; Kouroupis, D; Mantzouratou, P; Pantos, C; Papalois, A; Tourmousoglou, C; Vilaeti, AD | 1 |
| Bayes-Genis, A; Perea-Gil, I; Prat-Vidal, C | 1 |
| Cohen, S; Fredo, R; Freeman, I; Ruvinov, E | 1 |
| Batich, CD; Byrne, BJ; Cogle, CR; Ferreira, LF; Handberg, EM; Huo, T; Pepine, CJ; Petersen, JW; Qi, Y; Rocca, DG; Rubiano, A; Ruchaya, PJ; Simmons, CS; Wate, PS; Willenberg, BJ; Wise, EA | 1 |
| Lee, RJ; Mihardja, SS; Sievers, RE | 1 |
| Du, KT; Gu, Y; Lee, RJ; Mihardja, S; Sievers, RE; Yu, J | 1 |
| Kim, YH; Lee, J; Lee, KY; Lee, SK; Tan, CY | 1 |
| Castel, D; Cohen, S; Feinberg, MS; Goitein, O; Guetta, V; Klapper, L; Konen, E; Landa, N; Leor, J; Manczur, F; Petneházy, O; Shaul, M; Tsur-Gang, O; Tuvia, S; Willenz, U | 1 |
| Du, KT; Fang, Q; Gu, Y; Lee, RJ; Mihardja, SS; Sievers, RE; Wu, JC; Yu, J | 1 |
| Cohen, S; Leor, J; Ruvinov, E | 1 |
| Cohen, S; Harel-Adar, T; Ruvinov, E | 1 |
| Dreessen de Gervai, P; Gruwel, ML; Gussakovsky, E; Jilkina, O; Kupriyanov, V; Sun, J; Yang, Y | 1 |
| Binsalamah, ZM; Khan, AA; Paul, A; Prakash, S; Shum-Tim, D | 1 |
| Chen, G; Khan, A; Paul, A; Prakash, S; Rao, VT; Shum-Tim, D | 1 |
| de Jong, R; den Dekker, WK; Duckers, HJ; Hoefer, I; Houtgraaf, JH; Kazemi, K; Lewis, AL; Monkhorst, K; Pasterkamp, G; Stratford, PW; Tempel, D; van de Kamp, E; Wallrapp, C; Zijlstra, F | 1 |
| Farrell, KA; Holt, CM; Kassem, M; Lewis, AL; Malik, N; Wallrapp, C; Wright, EJ | 1 |
| Acarregui, A; Crisóstomo, V; Gallo, I; Gomez-Mauricio, RG; Hernández, RM; Martín-Cancho, MF; Orive, G; Pedraz, JL; Sánchez-Margallo, FM | 1 |
| Brodin, LA; Dellgren, G; Grinnemo, KH; Hao, X; Månsson-Broberg, A; Mooney, DJ; Siddiqui, AJ; Silva, EA; Sylvén, C; Wärdell, E | 1 |
| Cohen, S; Feinberg, MS; Freeman, I; Holbova, R; Landa, N; Leor, J; Miller, L; Shachar, M | 1 |
| Edelman, ER; Friedman, M; Grossman, W; Harada, K; Sellke, FW; Simons, M; Wang, SY | 1 |
| Edelman, ER; Laham, RJ; Pearlman, JD; Sellke, FW; Simons, M | 1 |
| Huwer, H; Menger, MD; Rissland, J; Schäfers, HJ; Vollmar, B; Welter, C; Winning, J | 1 |
1 review(s) available for glucuronic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'.
Topics: Alginates; Animals; Biocompatible Materials; Cell Transplantation; Cellular Microenvironment; Chitosan; Collagen; Drug Combinations; Fibrin; Gelatin; Glucuronic Acid; Hexuronic Acids; Humans; Hyaluronic Acid; Laminin; Materials Testing; Myocardial Infarction; Myocardium; Proteoglycans; Regeneration; Tissue Engineering; Tissue Scaffolds; Translational Research, Biomedical | 2015 |
2 trial(s) available for glucuronic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study.
Topics: Absorbable Implants; Adult; Aged; Alginates; Belgium; Calcium Gluconate; Feasibility Studies; Female; Germany; Glucuronic Acid; Heart Function Tests; Hexuronic Acids; Humans; Hydrogels; Injections, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Predictive Value of Tests; Regenerative Medicine; Surveys and Questionnaires; Time Factors; Tissue Engineering; Tissue Scaffolds; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results.
Topics: Aged; Alginates; Angina Pectoris; Collateral Circulation; Coronary Artery Bypass; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Creatinine; Delayed-Action Preparations; Drug Carriers; Feasibility Studies; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Glucuronic Acid; Heparin; Hexuronic Acids; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Neovascularization, Physiologic; Pericardium; Safety; Stroke Volume; Survival Rate | 1998 |
26 other study(ies) available for glucuronic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
Angiogenic nanodelivery systems for myocardial therapy.
Topics: Albumins; Alginates; Angiogenic Proteins; Cell Proliferation; Cells, Cultured; Drug Delivery Systems; Endothelium, Vascular; Glucuronic Acid; Hexuronic Acids; Humans; Myocardial Infarction; Nanoparticles | 2013 |
Injectable microsphere/hydrogel hybrid system containing heat shock protein as therapy in a murine myocardial infarction model.
Topics: Alginates; Animals; Apoptosis; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Gene Products, tat; Glucuronic Acid; Hexuronic Acids; HSP27 Heat-Shock Proteins; Hydrogels; In Situ Nick-End Labeling; Lactic Acid; Male; Microspheres; Myocardial Infarction; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins | 2013 |
Delivery of alginate-chitosan hydrogel promotes endogenous repair and preserves cardiac function in rats with myocardial infarction.
Topics: Alginates; Animals; Apoptosis; Biocompatible Materials; Cell Proliferation; Chitosan; Disease Models, Animal; Fibrosis; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Inflammation; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Regeneration; Regenerative Medicine; Shear Strength; Spectroscopy, Fourier Transform Infrared; Temperature; Tissue Engineering; Ventricular Remodeling | 2015 |
Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart.
Topics: Alginates; Animals; Biocompatible Materials; Cell Survival; Cells, Cultured; Cells, Immobilized; Chitosan; Collagen; Female; Glucuronic Acid; Glycerophosphates; Hexuronic Acids; Humans; Hydrogels; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Tissue Engineering | 2014 |
Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel.
Topics: Alginates; Analysis of Variance; Animals; Cell Culture Techniques; Cells, Cultured; Disease Models, Animal; Echocardiography, Doppler; Electrocardiography; Electrophysiologic Techniques, Cardiac; Glucuronic Acid; Heart Conduction System; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Mesenchymal Stem Cell Transplantation; Microscopy, Confocal; Myocardial Infarction; Random Allocation; Reference Values; Swine; Treatment Outcome | 2014 |
Purification of a low molecular weight fucoidan for SPECT molecular imaging of myocardial infarction.
Topics: Animals; Fucose; Glucuronic Acid; Isotope Labeling; Male; Molecular Weight; Myocardial Infarction; Myocardial Reperfusion Injury; Polysaccharides; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2014 |
Attenuation of post-infarction remodeling in rats by sustained myocardial growth hormone administration.
Topics: Alginates; Animals; Glucuronic Acid; Growth Hormone; Hexuronic Acids; Hydrogels; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Wistar; Tissue Scaffolds; Ventricular Remodeling | 2015 |
Spontaneous Coassembly of Biologically Active Nanoparticles via Affinity Binding of Heparin-Binding Proteins to Alginate-Sulfate.
Topics: Alginates; Animals; Biocompatible Materials; Disease Models, Animal; Drug Carriers; Glucuronic Acid; Heparin; Hexuronic Acids; Hindlimb; Ischemia; Myocardial Infarction; Nanoparticles; Protein Binding; Regenerative Medicine; Sulfates | 2016 |
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.
Topics: Alginates; Angiotensin I; Animals; Biocompatible Materials; Disease Models, Animal; Echocardiography; Gelatin; Glucuronic Acid; Hexuronic Acids; Hydrogels; Injections, Intralesional; Myocardial Infarction; Peptide Fragments; Rats; Rats, Sprague-Dawley; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2016 |
The effect of polypyrrole on arteriogenesis in an acute rat infarct model.
Topics: Alginates; Animals; Arteries; Cell Adhesion; Cell Proliferation; Cell Shape; Cell Survival; Disease Models, Animal; Electric Conductivity; Endothelial Cells; Female; Glucuronic Acid; Hexuronic Acids; Humans; Myocardial Infarction; Organogenesis; Polymers; Pyrroles; Rats; Rats, Sprague-Dawley; Tissue Scaffolds | 2008 |
The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model.
Topics: Alginates; Animals; Cell Adhesion; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Humans; Myocardial Infarction; Oligopeptides; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction.
Topics: Alginates; Apoptosis; Cell Hypoxia; Cell Line; Cell Proliferation; Cell Survival; Delayed-Action Preparations; Glucuronic Acid; Heat-Shock Proteins; Hexuronic Acids; HIV; HSP27 Heat-Shock Proteins; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Lactic Acid; Microspheres; Molecular Chaperones; Myoblasts, Cardiac; Myocardial Infarction; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Fusion Proteins; tat Gene Products, Human Immunodeficiency Virus | 2009 |
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
Topics: Alginates; Animals; Biocompatible Materials; Disease Models, Animal; Feasibility Studies; Female; Glucuronic Acid; Heart Rate; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Injections, Intralesional; Myocardial Infarction; Stroke Volume; Swine; Ventricular Remodeling | 2009 |
The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat.
Topics: Alginates; Animals; Cell Survival; Disease Models, Animal; Echocardiography; Female; Glucuronic Acid; Hexuronic Acids; Humans; Mesenchymal Stem Cells; Microspheres; Myocardial Infarction; Oligopeptides; Polymerase Chain Reaction; Rats; Rats, Nude; Tissue Engineering | 2010 |
The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction.
Topics: Alginates; Animals; Animals, Newborn; Apoptosis; Biocompatible Materials; Blotting, Western; Cells, Cultured; Disease Models, Animal; Female; Glucuronic Acid; Hepatocyte Growth Factor; Hexuronic Acids; Immunohistochemistry; Injections; Insulin-Like Growth Factor I; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2011 |
Bioengineering the infarcted heart by applying bio-inspired materials.
Topics: Alginates; Animals; Biocompatible Materials; Bioengineering; Disease Models, Animal; Drug Carriers; Extracellular Matrix Proteins; Glucuronic Acid; Hexuronic Acids; Injections; Intercellular Signaling Peptides and Proteins; Liposomes; Macrophages; Mice; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phosphatidylserines; Rats; Regeneration; Regenerative Medicine; Time Factors; Tissue Scaffolds; Ventricular Remodeling | 2011 |
MRI study of cryoinjury infarction in pig hearts: i. Effects of intrapericardial delivery of bFGF/VEGF embedded in alginate beads.
Topics: Alginates; Animals; Cold Temperature; Drug Delivery Systems; Fibroblast Growth Factor 2; Fluorescence; Gadolinium; Gadolinium DTPA; Glucuronic Acid; Heart Ventricles; Hexuronic Acids; Humans; Implants, Experimental; Kinetics; Magnetic Resonance Imaging; Microspheres; Myocardial Infarction; Perfusion; Pericardium; Postmortem Changes; Signal Processing, Computer-Assisted; Sus scrofa; Tetrazolium Salts; Time Factors; Vascular Endothelial Growth Factor A | 2012 |
Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model.
Topics: Alginates; Analysis of Variance; Animals; Chitosan; Cytokines; Electrocardiography; Female; Glucuronic Acid; Hexuronic Acids; Immunohistochemistry; Myocardial Infarction; Nanoparticles; Neovascularization, Physiologic; Particle Size; Pharmaceutical Vehicles; Placenta Growth Factor; Pregnancy Proteins; Rats; Rats, Inbred Lew; Stroke Volume; Ventricular Remodeling | 2011 |
Genipin-cross-linked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction.
Topics: Adipocytes; Alginates; Animals; Cell Differentiation; Cells, Cultured; Chitosan; Coronary Vessels; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Humans; Iridoids; Male; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Rats; Rats, Inbred Lew; Regenerative Medicine; Stem Cell Transplantation; Stem Cells; Vascular Endothelial Growth Factor A | 2012 |
Feasibility of intracoronary GLP-1 eluting CellBead™ infusion in acute myocardial infarction.
Topics: Acute Disease; Alginates; Animals; Apoptosis; Balloon Occlusion; Cell- and Tissue-Based Therapy; Female; Glucagon-Like Peptide 1; Glucuronic Acid; Hexuronic Acids; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Pilot Projects; Swine | 2013 |
Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts.
Topics: Alginates; Anatomy, Cross-Sectional; Animals; Apoptosis; Cardiotonic Agents; Cell Survival; Disease Models, Animal; Drug Delivery Systems; Echocardiography; Glucagon-Like Peptide 1; Glucuronic Acid; Heart Failure; Hexuronic Acids; Humans; In Situ Nick-End Labeling; Inflammation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Infarction; Myofibroblasts; Neovascularization, Pathologic; Recombinant Fusion Proteins; Sus scrofa; Ventricular Function, Left | 2012 |
A preliminary approach to the repair of myocardial infarction using adipose tissue-derived stem cells encapsulated in magnetic resonance-labelled alginate microspheres in a porcine model.
Topics: Adipose Tissue; Alginates; Animals; Cells, Cultured; Disease Models, Animal; Glucuronic Acid; Hexuronic Acids; Magnetic Resonance Imaging; Microspheres; Myocardial Infarction; Random Allocation; Stem Cell Transplantation; Swine | 2013 |
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction.
Topics: Alginates; Animals; Aorta; Becaplermin; Echocardiography; Glucuronic Acid; Heart; Hexuronic Acids; Hydrogels; In Vitro Techniques; Injections; Iodine Radioisotopes; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Neovascularization, Physiologic; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Radiography; Random Allocation; Rats; Rats, Inbred F344; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Left | 2007 |
Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat.
Topics: Alginates; Animals; Biocompatible Materials; Cicatrix; Drug Administration Schedule; Drug Evaluation, Preclinical; Glucuronic Acid; Hexuronic Acids; Hydrogels; Hypertrophy, Left Ventricular; Injections, Intralesional; Male; Materials Testing; Myocardial Infarction; Myocytes, Cardiac; Random Allocation; Rats; Rats, Sprague-Dawley; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling; Viscosity | 2008 |
Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine Diphosphate; Alginates; Animals; Arginine; Calcimycin; Coronary Circulation; Coronary Vessels; Drug Carriers; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Glucuronic Acid; Heart; Hexuronic Acids; Indomethacin; Ketanserin; Male; Microcirculation; Muscle Relaxation; Myocardial Infarction; Myocardium; Nitroarginine; Nitroprusside; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Sepharose; Serotonin; Swine; Thromboxane A2; Vasodilation | 1994 |
Microvascularization and ventricular function after local alginate-encapsulated angiogenic growth factor treatment in a rat cryothermia-induced myocardial infarction model.
Topics: Alginates; Angiogenesis Inducing Agents; Animals; Cold Temperature; Disease Models, Animal; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Microcirculation; Myocardial Infarction; Neovascularization, Physiologic; Rats; Ventricular Function, Left | 2001 |